DTP-HepB vaccine

DTP-HepB
Combination of
DTP vaccine	Vaccine
Hepatitis B vaccine	Vaccine
Clinical data
Trade names	Tritanrix-HepB
AHFS/Drugs.com	UK Drug Information
Routes of; administration	Intramuscular injection
ATC code	J07CA05 (WHO) ;

DTP-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and whole-cell pertussis and hepatitis B (recombinant) vaccine (adsorbed) or DTP-Hep B. It protects against the infectious diseases diphtheria, tetanus, pertussis, and hepatitis B.[1]

A branded formulation, Tritanrix-HepB manufactured by GlaxoSmithKline, was granted marketing approval in the EU in 1996. Marketing approval lapsed in 2014.[2]

A review conducted in 2012 concluded that there was insufficient evidence to determine differences in safety and efficacy between DTP-HepB vaccine and Hib vaccine administered separately and pentavalent DTP-HepB-Hib vaccine.[3]

References

Organization, World Health; Biologicals, World Health Organization Department of Immunization, Vaccines and (2004). Immunization in Practice: A Practical Guide for Health Staff. World Health Organization. p. 18. ISBN 9789241546515. Retrieved 15 July 2018.
"Tritanrix HepB". European Medicines Agency. Retrieved 14 July 2018.
Bar-On, Edna S; Goldberg, Elad; Hellmann, Sarah; Leibovici, Leonard (2012). "Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)". Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD005530.pub3. ISSN 1465-1858.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Organization, World Health; Biologicals, World Health Organization Department of Immunization, Vaccines and (2004). Immunization in Practice: A Practical Guide for Health Staff. World Health Organization. p. 18. ISBN 9789241546515. Retrieved 15 July 2018.

[2] "Tritanrix HepB". European Medicines Agency. Retrieved 14 July 2018.

[Bar-OnGoldberg2012-3] Bar-On, Edna S; Goldberg, Elad; Hellmann, Sarah; Leibovici, Leonard (2012). "Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)". Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD005530.pub3. ISSN 1465-1858.